Existing investors are joined by YK Bioventures, bringing total funding to $26M. The additional raise will accelerate the company's pipeline and expand their unique approach for finding new functional pockets on challenging targets.

Think Bioscience is reimagining synthetic biology by using living systems to guide the design and assembly of better medicines. The company programs microbes to build small molecules that bind to functional pockets, and they use these pockets to find hits in drug-like space. The platform technology has been expanded to protein tyrosine phosphatases (PTPs), kinases (PTKs), proteases, and GTPases.